The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs-Reference-Cited by-同舟云学术

The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs

Published:2023-06-05 Issue:12 Volume:66 Page:7698-7729
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Geurs Silke¹²,Clarisse Dorien²³,De Bosscher Karolien²³,D’hooghe Matthias¹^ORCID

Affiliation:

1. SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, B-9000 Ghent, Belgium

2. Translational Nuclear Receptor Research, VIB-UGent Center for Medical Biotechnology, Technologiepark-Zwijnaarde 75, B-9052 Ghent, Belgium

3. Department of Biomolecular Medicine, Ghent University, Technologiepark-Zwijnaarde 75, B-9052 Ghent, Belgium

Funder

Fonds Wetenschappelijk Onderzoek

Bijzonder Onderzoeksfonds UGent

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00226

Reference218 articles.

1. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men

2. The many roles of histone deacetylases in development and physiology: implications for disease and therapy

3. Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions

4. ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS

5. Chemical Studies of Histone Acetylation

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological function and small molecule inhibitors of histone deacetylase 11;European Journal of Medicinal Chemistry;2024-10

2. Heterocycles–Containing HDAC Inhibitors Active in Cancer: An Overview of the Last Fifteen Years;ChemMedChem;2024-08-29

3. Replacement of the hydroxamic acid group in the selective HDAC8 inhibitor PCI-34051;Bioorganic & Medicinal Chemistry Letters;2024-08

4. Preferential HDAC6 inhibitors derived from HPOB exhibit synergistic antileukemia activity in combination with decitabine;European Journal of Medicinal Chemistry;2024-06

5. Histone deacetylase (HDAC) inhibitor specificity determinants are preserved in a class of dual HDAC/non-covalent proteasome inhibitors;Bioorganic & Medicinal Chemistry;2024-04